•
Sep 30, 2021

CME Group Q3 2021 Earnings Report

CME Group reported financial results with revenue of $1.1 billion and operating income of $614 million.

Key Takeaways

CME Group's Q3 2021 results showed robust volume growth as clients managed risks amid economic uncertainty. Average daily volume grew 14% year over year, driven by interest rates, energy, and options products. The company also focused on product innovation and strategic execution, including the OSTTRA joint venture.

Average daily volume grew 14% year over year.

Double-digit growth in interest rates, energy and options products.

Non-U.S. volumes increased 13% to 5 million contracts per day.

Delivered 70 new products and solutions, including Micro Treasury futures and new ESG-focused products.

Total Revenue
$1.11B
Previous year: $1.08B
+2.7%
EPS
$1.6
Previous year: $1.38
+15.9%
ADV Contracts
17.79M
Previous year: 15.6M
+14.0%
Avg. Rate per Contract
$0.677
Previous year: $0.716
-5.4%
Gross Profit
$911M
Previous year: $864M
+5.4%
Cash and Equivalents
$1.46B
Previous year: $1.33B
+9.6%
Free Cash Flow
$600M
Previous year: $263M
+128.0%
Total Assets
$187B
Previous year: $126B
+48.5%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group did not provide specific forward guidance in the provided document.

Revenue & Expenses

Visualization of income flow from segment revenue to net income